ÃÖ±Ù º£¸µ°ÅÀΰÖÇÏÀÓÀÌ »ý¹° ÀǾàÇ°(biopharmaceutical) ȸ»ç ¾Öºí¸µ½º»ç¿Í 10°¡ÁöÀÇ ³ª³ë¹Ùµð(Nanobodies) Ä¡·áÁ¦ÀÇ °³¹ß ¹× »óǰȸ¦ À§ÇÑ ±Û·Î¹ú Àü·«Àû Á¦ÈÞ¸¦ ü°áÇß´Ù.
12ÀÏ º£¸µ°ÅÀΰÖÇÏÀÓ¿¡ µû¸£¸é ¾Öºí¸µ½º´Â °øµ¿¿¬±¸ ±â°£ µ¿¾È ÁÖ½ÄÅõÀÚ ºñ¿ëÀ¸·Î Á¦¾ÈÇÑ Ãµ5¹é¸¸ À¯·Î¸¦ Æ÷ÇÔÇØ 7õ 5¹é¸¸ À¯·Î¸¦ ¹Þ°Ô µÈ´Ù.
Ãß°¡·Î ¾Öºí¸µ½º»ç´Â °³¹ßµÈ °¢ ³ª³ë¹Ùµð °³¹ß¼º°ø´Ü°è¿¡ µû¶ó Á¦Ç°°³¹ßºñ µî ÃÖ´ë 1¾ï 2õ 5¹é¸¸ À¯·Î¿Í ·Î¿Æ¼¸¦ ÁöºÒ¹Þ´Â´Ù.
ÀÌ·Î½á ¾Öºí¸µ½º¿Í º£¸µ°ÅÀΰÖÇÏÀÓÀº ¸é¿ªÇÐ, Á¾¾çÇÐ, È£Èí±âÇÐÀ» ºñ·Ô ´Ù°¢ÀûÀÎ Ä¡·á ¿µ¿ªÀ» ¸ñÇ¥·Î ³ª³ë¹Ùµð °³¹ß¿¡ °øµ¿Çù·ÂÇÏ°Ô µÈ´Ù.
µÎ ȸ»ç ¸ðµÎ ȯÀÚ¿¡°Ô ÇÊ¿äÇÑ ³ª³ë¹Ùµð¸¦ ±âÃÊ·Î ÇÏ´Â Á¦Ç°À» ½Å¼ÓÇÏ°Ô °ø±ÞÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çù·ÂÇÏ°Ô µÈ´Ù.
º£¸µ°ÅÀΰÖÇÏÀÓÀº ÀÌ Çù·ÂÀ» ÅëÇÑ ¸ðµç Á¦Ç°ÀÇ °³¹ß, Á¦Á¶, »óÇ°È¿¡ µ¶Á¡±ÇÀ» °¡Áö°Ô µÇ¸ç, ¾Öºí¸µ½º´Â À¯·´¿¡¼ °øµ¿ÆǸűÇ(co-promotion)À» ±ì´Â´Ù.
¾Öºí¸µ½º ÃÖ°í°æ¿µÀÚÀÌÀÚ È¸ÀåÀÎ ¿¡µåÀ© ¸ð¼¼ ¹Ú»ç(Dr EdwinMoses,CEOandChairmanofAblynx)´Â, ¡°¾Öºí¸µ½º°¡ Çõ½ÅÀûÀÎ ³ª³ë¹Ùµð Ä¡·á¹ýÀ» °³¹ßÇϱâÀ§ÇØ ¸ÎÀº °è¾à Áß °¡Àå Å« ±Ô¸ðÀÌ´Ù. °·ÂÇÑ ³ª³ë¹Ùµð?ÀÇ ÀÌÁ¡À» ÃæºÐÈ÷ ÀÌ¿ëÇÏ°í, ´Ù°¢ÀûÀÎ Ä¡·á¿µ¿ª¿¡ °ÉÄ£ Çõ½ÅÀûÀÎ Á¦Ç°°³¹ßÀ» À§ÇØ º£¸µ°ÅÀΰÖÇÏÀÓ°ú ÇÔ²² ÀÏÇÔÀ¸·Î½á ´õ¿í µ·µ¶ÇÑ °ü°è¸¦ ¸Î°Ô µÇ¾î ±â»Ú°Ô »ý°¢ÇÑ´Ù. À̹ø Àü·«Àû Á¦ÈÞ´Â ¾Öºí¸µ½ºÀÇ Á¦Ç° ÆÄÀÌÇÁ¶óÀÎÀ» °È½ÃÅ°´Â ±âȸ°¡ µÉ °ÍÀÌ´Ù.¡±¶ó°í ¸»Çß´Ù.
º£¸µ°ÅÀΰÖÇÏÀÓ ÀÌ»çȸÀÇ ºÎȸÀåÀÌÀÚ, ¿¬±¸ °³¹ß ºÐ¾ß Ã¥ÀÓÀÚÀÎ ¾Èµå·¹¾Æ½º ¹Ù³Ê ¹Ú»ç(Dr Andreas Barner, Vice-Chairman of the Board of Managing Directors and Head of Corporate Board Division Pharma Research, Development and Medicine)´Â ¡°º£¸µ°ÅÀΰÖÇÏÀÓÀº Çõ½ÅÀûÀÎ ³ª³ë¹Ùµð Á¢±Ù¹ýÀ» ¹ÙÅÁÀ¸·Î ÇÏ´Â ¾Öºí¸µ½º¿ÍÀÇ Çù·ÂÀÌ °ÈµÇ±â¸¦ ±â´ëÇÏ°í ÀÖ´Ù. ÀÌ·¯ÇÑ Æø³ÐÀº °øµ¿Çù·ÂÀÌ ÇöÀç ÀûÀýÇÏ°Ô Ä¡·á¸¦ ¹ÞÀ» ¼ö ¾ø¾î¼ °í»ýÇÏ°í Àִ ȯÀڵ鿡°Ô µ¹Æı¸°¡ µÇ¾îÁÙ °ÍÀ¸·Î ±â´ëÇÑ´Ù.¡±°í µ¡ºÙ¿´´Ù.